Genome Editing in Engineered T Cells for Cancer Immunotherapy

Advanced gene transfer technologies and profound immunological insights have enabled substantial increases in the efficacy of anticancer adoptive cellular therapy (ACT). In recent years, the U.S. Food and Drug Administration and European Medicines Agency have approved six engineered T cell therapeut...

Full description

Bibliographic Details

Published in:	Human gene therapy Vol. 34; no. 17-18; p. 853
Main Authors:	Bonini, Chiara, Chapuis, Aude G, Hudecek, Michael, Guedan, Sonia, Magnani, Chiara, Qasim, Waseem
Format:	Journal Article
Language:	English
Published:	United States 01.09.2023
Subjects:	Anniversaries and Special Events B-Lymphocytes Gene Editing Humans Immunotherapy Neoplasms - genetics Neoplasms - therapy T-Lymphocytes United States United States CRISPR CAR TCR
ISSN:	1557-7422, 1557-7422
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!